4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-21-046027
10% owner bought 750,000 shares at $16.00 ($12,000,000)
- 10% owner acquired 3,201,156 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hardie Robert D. 10% owner | 2021-07-06 | Conversion | +1,124,830 | 1,124,830 | I | ||
| Hardie Robert D. 10% owner | 2021-07-06 | Conversion | +2,076,326 | 3,201,156 | I | ||
| Hardie Robert D. 10% owner | 2021-07-06 | Purchase | +750,000 | $16.00 | $12,000,000 | 3,951,156 | I |
| Derivatives | |||||||
| Hardie Robert D. 10% owner | 2021-07-06 | Conversion · Series A-1 Preferred Stock | −1,124,830 | 0 | I | ||
| Hardie Robert D. 10% owner | 2021-07-06 | Conversion · Series B Preferred Stock | −2,076,326 | 0 | I | ||
| Open-market purchases · 750,000 sh · avg $16.00 · $12,000,000 | |||||||
Loading xslF345X03/doc4.xml…